These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23568616)

  • 21. Tobramycin inhalation powder: an efficient and efficacious therapy for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis.
    Somayaji R; Parkins MD
    Ther Deliv; 2015 Feb; 6(2):121-37. PubMed ID: 25690082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa Biofilms.
    Bahamondez-Canas TF; Ferrati S; Moraga-Espinoza DF; Smyth HDC
    J Pharm Sci; 2018 Aug; 107(8):2172-2178. PubMed ID: 29698726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.
    Dimer F; de Souza Carvalho-Wodarz C; Haupenthal J; Hartmann R; Lehr CM
    Pharm Res; 2015 Dec; 32(12):3850-61. PubMed ID: 26113237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Parkins MD; Elborn JS
    Expert Rev Respir Med; 2011 Oct; 5(5):609-22. PubMed ID: 21955231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled tobramycin: not just for cystic fibrosis anymore?
    Lobue PA
    Chest; 2005 Apr; 127(4):1098-101. PubMed ID: 15821180
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy.
    Buttini F; Balducci AG; Colombo G; Sonvico F; Montanari S; Pisi G; Rossi A; Colombo P; Bettini R
    Int J Pharm; 2018 Sep; 548(1):182-191. PubMed ID: 29883795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
    Kukut Hatipoglu M; Hickey AJ; Garcia-Contreras L
    Int J Pharm; 2018 Oct; 549(1-2):306-316. PubMed ID: 30077761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of combined tobramycin-clarithromycin on Mycobacterium tuberculosis isolates.
    Stoffels K; Traore H; Vanderbist F; Fauville-Dufaux M
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):1041-4. PubMed ID: 19723387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler.
    Parumasivam T; Leung SS; Tang P; Mauro C; Britton W; Chan HK
    AAPS J; 2017 Jan; 19(1):191-202. PubMed ID: 27679516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation.
    Belotti S; Rossi A; Colombo P; Bettini R; Rekkas D; Politis S; Colombo G; Balducci AG; Buttini F
    Eur J Pharm Biopharm; 2015 Jun; 93():165-72. PubMed ID: 25845771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dry powder inhalers in cystic fibrosis].
    Steinkamp G
    Pneumologie; 2014 Jun; 68(6):378-85. PubMed ID: 24664997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation.
    Miller DP; Tan T; Nakamura J; Malcolmson RJ; Tarara TE; Weers JG
    Mol Pharm; 2017 Jun; 14(6):1950-1960. PubMed ID: 28418683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers.
    Newhouse MT; Hirst PH; Duddu SP; Walter YH; Tarara TE; Clark AR; Weers JG
    Chest; 2003 Jul; 124(1):360-6. PubMed ID: 12853545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
    Stelmach I; Korzeniewska A; Stelmach W
    Respiration; 2008; 75(2):178-81. PubMed ID: 17435382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
    Young PM; Crapper J; Philips G; Sharma K; Chan HK; Traini D
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):138-47. PubMed ID: 24004178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
    Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis.
    Nolan K; Knight H; Clark P
    Lancet Respir Med; 2013 Apr; 1(2):102-3. PubMed ID: 24429083
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.
    Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM
    Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.